Log in
Enquire now
‌

US Patent 11040981 Pyrrolotriazine compounds and methods of inhibiting TAM kinases

Patent 11040981 was granted and assigned to Syros Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Syros Pharmaceuticals
Syros Pharmaceuticals
Current Assignee
Syros Pharmaceuticals
Syros Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11040981
Date of Patent
June 22, 2021
Patent Application Number
16755051
Date Filed
October 9, 2018
Patent Primary Examiner
‌
Venkataraman Balasubramanian
Patent abstract

Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11040981 Pyrrolotriazine compounds and methods of inhibiting TAM kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.